Search Results 1591-1600 of 17385 for monoclonal antibody

  1. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

    Participation eligibility · HBV surface antigen (HBsAg) positive; · HBV surface antigen (HBsAg) negative, HBV surface antibody (anti-HBs) positive and/or HBV core ...

  2. Dual focus, one goal: Neuro-ophthalmology provides comprehensive evaluation for an accurate diagnosis - Mayo Clinic

    Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease. Posterior cortical atrophy. Giant cell arteritis. Ischemic optic neuropathy ...

  3. Hematology - Clinical trials

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  4. Clinical trials - Oncology (Medical)

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  5. Clinical trials - Oncology (Medical)

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  6. New collaboration on COVID-19 response to include new serology test - Mayo Clinic News Network

    announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.

  7. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

    Subject has received prior treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody-containing regimen for at least 2 ...

  8. 7T MR Imaging in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) - Mayo Clinic

    Detection of clinically relevant donor-specific allo-Human Leukocyte Antigen (HLA) reactive antibodies ... Clinical diagnosis of autoimmune epilepsy, supported by ...

  9. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Must be refractory to anti-CD38 antibody (e.g., daratumumab or isatuximab) ... antibody result and known quantitative hepatitis C [HCV] ribonucleic acid ...

  10. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    ... antibody. Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or hepatitis B core antibody [HBcAb]). Participants ...